Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2013 1
2015 1
2018 1
2020 3
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Liver metastasis 13 years after the resection of a malignant triton tumor originating in the duodenum.
Ohashi K, Asahi Y, Kamiyama T, Kakisaka T, Orimo T, Nagatsu A, Sakamoto Y, Kamachi H, Takagi T, Otsuka T, Mitsuhashi T, Sugita S, Hasegawa T, Taketomi A. Ohashi K, et al. Among authors: takagi t. Int Cancer Conf J. 2022 Mar 15;11(3):178-183. doi: 10.1007/s13691-022-00544-z. eCollection 2022 Jul. Int Cancer Conf J. 2022. PMID: 35669906 Free PMC article.
Malignant triton tumor of the duodenum: report of a case.
Asahi Y, Nakagawa T, Nakanishi K, Takagi T, Yoshikawa H, Wakizaka K, Yokoyama R, Takahashi M, Sasaki F. Asahi Y, et al. Among authors: takagi t. Int Cancer Conf J. 2018 Mar 13;7(2):52-58. doi: 10.1007/s13691-018-0320-7. eCollection 2018 Apr. Int Cancer Conf J. 2018. PMID: 31149515 Free PMC article.
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.
Sho T, Suda G, Yamamoto Y, Furuya K, Baba M, Ogawa K, Kubo A, Tokuchi Y, Fu Q, Yang Z, Kimura M, Kitagataya T, Maehara O, Ohnishi S, Nakamura A, Yamada R, Ohara M, Kawagishi N, Natsuizaka M, Nakai M, Suzuki K, Izumi T, Meguro T, Terashita K, Takagi T, Ito J, Kobayashi T, Miyagishima T, Sakamoto N. Sho T, et al. Among authors: takagi t. Cancers (Basel). 2022 Aug 15;14(16):3938. doi: 10.3390/cancers14163938. Cancers (Basel). 2022. PMID: 36010930 Free PMC article.
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.
Sho T, Suda G, Ogawa K, Shigesawa T, Suzuki K, Nakamura A, Ohara M, Umemura M, Kawagishi N, Natsuizaka M, Nakai M, Morikawa K, Furuya K, Baba M, Ito J, Yamamoto Y, Kobayashi T, Meguro T, Saga A, Miyagishima T, Terasita K, Takagi T, Kamiyama T, Taketomi A, Sakamoto N. Sho T, et al. Among authors: takagi t. Hepatol Res. 2020 Aug;50(8):966-977. doi: 10.1111/hepr.13511. Epub 2020 Jul 9. Hepatol Res. 2020. PMID: 32562334
Single-stage endoscopic treatment for mild to moderate acute cholangitis associated with choledocholithiasis: a multicenter, non-randomized, open-label and exploratory clinical trial.
Eto K, Kawakami H, Haba S, Yamato H, Okuda T, Yane K, Hayashi T, Ehira N, Onodera M, Matsumoto R, Matsubara Y, Takagi T, Sakamoto N; Hokkaido Interventional EUS/ERCP study (HONEST) group. Eto K, et al. Among authors: takagi t. J Hepatobiliary Pancreat Sci. 2015 Dec;22(12):825-30. doi: 10.1002/jhbp.296. Epub 2015 Nov 25. J Hepatobiliary Pancreat Sci. 2015. PMID: 26510180 Clinical Trial.
Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.
Takahashi M, Tanaka T, Takahashi H, Hoshino Y, Nagashima S, Jirintai, Mizuo H, Yazaki Y, Takagi T, Azuma M, Kusano E, Isoda N, Sugano K, Okamoto H. Takahashi M, et al. Among authors: takagi t. J Clin Microbiol. 2010 Apr;48(4):1112-25. doi: 10.1128/JCM.02002-09. Epub 2010 Jan 27. J Clin Microbiol. 2010. PMID: 20107086 Free PMC article.
11 results